Roche has introduced the Elecsys PRO-C3 test, a breakthrough diagnostic solution that delivers liver fibrosis severity assessment results in just 18 minutes, addressing a critical gap in managing metabolic dysfunction-associated steatotic liver disease (MASLD) that affects approximately 30% of the global population.

German biotechnology company PEPperPRINT has launched its next-generation peptide microarray platform, cLIFT (combinatorial Laser-Induced Forward Transfer), marking a significant advancement in high-density peptide screening capabilities for clinical research and diagnostic applications.

Micronic has introduced the Tube Reader DT520, a next-generation scanning solution designed to revolutionise sample identification workflows in clinical laboratories and research facilities. The compact device delivers sub-second barcode reading capabilities across multiple tube formats, addressing critical efficiency demands in high-throughput laboratory environments.

Evosep has unveiled its latest separation technology, the Evosep Eno™, designed to advance high-throughput LC-MS proteomics for pharmaceutical and biotech applications. The announcement, made at the Annual Conference on Mass Spectrometry (ASMS) in Baltimore, positions the platform as a cornerstone technology for next-generation proteomics workflows.

Beckman Coulter Life Sciences has introduced the CytoFLEX mosaic Spectral Detection Module, the industry’s first modular approach to spectral flow cytometry. This innovative technology, compatible with existing CytoFLEX LX and S Flow Cytometers, delivers superior fluorescence sensitivity with up to 88 detection channels and can detect nanoparticles as small as 80 nm.